The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis
出版年份 2021 全文链接
标题
The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis
作者
关键词
Intraperitoneal chemotherapy, Peritoneal carcinomatosis, Ovarian cancer, Cathepsin B-Specific doxorubicin prodrug nanoparticle, Nano-sized drug delivery
出版物
BIOMATERIALS
Volume 279, Issue -, Pages 121189
出版商
Elsevier BV
发表日期
2021-10-20
DOI
10.1016/j.biomaterials.2021.121189
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity
- (2021) Suah Yang et al. BIOMATERIALS
- Establishment and preclinical application of a patient-derived xenograft model for uterine cancer
- (2021) Soo Young Jeong et al. GYNECOLOGIC ONCOLOGY
- Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy
- (2021) Jiwoong Choi et al. ACS Nano
- A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneity
- (2020) Vivian P. Bastiaenen et al. LABORATORY INVESTIGATION
- Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy
- (2020) Man Kyu Shim et al. BIOMATERIALS
- Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance
- (2020) Jinseong Kim et al. JOURNAL OF CONTROLLED RELEASE
- Pharmacokinetics of the intraperitoneal nanoparticle pegylated liposomal doxorubicin in patients with peritoneal metastases
- (2019) Paul H. Sugarbaker et al. EJSO
- Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy
- (2019) Wooram Um et al. BIOMATERIALS
- Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?
- (2019) Abdullah Al Shoyaib et al. PHARMACEUTICAL RESEARCH
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- (2018) Willemien J. van Driel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy
- (2018) Man Kyu Shim et al. JOURNAL OF CONTROLLED RELEASE
- Applications of π-π stacking interactions in the design of drug-delivery systems
- (2018) Wan-Ru Zhuang et al. JOURNAL OF CONTROLLED RELEASE
- Effects of tumor microenvironments on targeted delivery of glycol chitosan nanoparticles
- (2017) Ji Young Yhee et al. JOURNAL OF CONTROLLED RELEASE
- Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery
- (2017) Ning Gao et al. Theranostics
- Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
- (2017) Eun Jin Heo et al. Cancer Research and Treatment
- Cathepsin B-Specific Metabolic Precursor for In Vivo Tumor-Specific Fluorescence Imaging
- (2016) Man Kyu Shim et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer
- (2016) Karol Polom et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy
- (2016) L. Simon-Gracia et al. MOLECULAR CANCER THERAPEUTICS
- Anthracyclines induce double-strand DNA breaks at active gene promoters
- (2015) Fan Yang et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances
- (2014) Anaïs Pitto-Barry et al. Polymer Chemistry
- Doxorubicin, DNA torsion, and chromatin dynamics
- (2013) Fan Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Optimization of Drug Delivery Systems for Intraperitoneal Therapy to Extend the Residence Time of the Chemotherapeutic Agent
- (2013) L. De Smet et al. TheScientificWorldJOURNAL
- Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis
- (2011) Michael E. Werner et al. BIOMATERIALS
- Intraperitoneal therapy for peritoneal cancer
- (2010) Ze Lu et al. Future Oncology
- Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
- (2009) Adriana Albini et al. JNCI-Journal of the National Cancer Institute
- Intraperitoneal chemotherapy: standard of care for patients with minimal residual stage III ovarian cancer?
- (2008) Mohan K Tummala et al. Expert Review of Anticancer Therapy
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started